Secreted FGFR3, but not FGFR1, inhibits lens fiber differentiation

被引:0
|
作者
Govindarajan, V [1 ]
Overbeek, PA [1 ]
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
来源
DEVELOPMENT | 2001年 / 128卷 / 09期
关键词
FGF; FGFR1; FGFR3; lens; differentiation; transgenic mice;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The vertebrate lens has a distinct polarity with cuboidal epithelial cells on the anterior side and differentiated fiber cells on the posterior side. It has been proposed that the anterior-posterior polarity of the lens is imposed by factors present in the ocular media surrounding the lens (aqueous and vitreous humor). The differentiation factors have been hypothesized to be members of the fibroblast growth factor (FGF) family. Though FGFs have been shown to be sufficient for induction of lens differentiation both in vivo and in vitro, they have not been demonstrated to be necessary for endogenous initiation of fiber cell differentiation. To test this possibility, we have generated transgenic mice with ocular expression of secreted self-dimerizing versions of FGFR1 (FR1) and FGFR3 (FR3), Expression of FR3, but not FR1, leads to an expansion of proliferating epithelial cells from the anterior to the posterior side of the lens due to a delay in the initiation of fiber cell differentiation. This delay is most apparent postnatally and correlates with appropriate changes in expression of marker genes including p57(KIP2), Maf and Prox1. Phosphorylation of Erk1 and Erk2 was reduced in the lenses of FR3 mice compared with nontransgenic mice. Though differentiation was delayed in FR3 mice, the lens epithelial cells still retained their intrinsic ability to respond to FGF stimulation. Based on these results we propose that the initiation of lens fiber cell differentiation in mice requires FGF receptor signaling and that one of the lens differentiation signals in the vitreous humor is a ligand for FR3, and is therefore likely to be an FGF or FGF-like factor.
引用
收藏
页码:1617 / 1627
页数:11
相关论文
共 50 条
  • [31] FGFR3 mutations and FGFR3 protein overexpression in superficial bladder tumors
    Hernandez, S.
    Lopez-Knowles, E.
    Murta, C.
    Kogevinas, M.
    Lloreta, J.
    Carrato, A.
    Tradon, A.
    Serra, C.
    Malats, N.
    Real, F. X.
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (14) : 808 - 808
  • [32] Comparative analysis of FGFR1, FGFR3 and FGFR4 tyrosine kinase activities expressed as chimeric receptors in PC12 cells.
    Raffioni, S
    Bradshaw, RA
    FASEB JOURNAL, 1997, 11 (09): : A1057 - A1057
  • [33] Identification of pathogenic FGFR1, FGFR2, and FGFR3 alterations in cell-free DNA (cfDNA) from patients with metastatic breast cancer
    Taylor, Mary Love
    Mayro, Benjamin
    Drusbosky, Leylah
    Batchelder, Robin
    Marcom, P. Kelly
    Anders, Carey
    Force, Jeremy
    CANCER RESEARCH, 2021, 81 (04)
  • [34] Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas
    Granberg, Kirsi J.
    Annala, Matti
    Lehtinen, Birgitta
    Kesseli, Juha
    Haapasalo, Joonas
    Ruusuvuori, Pekka
    Yli-Harja, Olli
    Visakorpi, Tapio
    Haapasalo, Hannu
    Nykter, Matti
    Zhang, Wei
    NEURO-ONCOLOGY, 2017, 19 (09) : 1206 - 1216
  • [35] INHIBITION OF FIBER CELL-DIFFERENTIATION IN TRANSGENIC MICE EXPRESSING A DOMINANT-NEGATIVE FGFR1 RECEPTOR IN THE LENS
    ROBINSON, ML
    OVERBEEK, PA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S261 - S261
  • [36] Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor
    Verstovsek, S.
    Subbiah, V.
    Masarova, L.
    Yin, C. Cameron
    Tang, G.
    Manshouri, T.
    Asatiani, E.
    Daver, N. G.
    ANNALS OF ONCOLOGY, 2018, 29 (08) : 1880 - 1882
  • [37] FGFR1 and FGFR2 in fibrolamellar carcinoma
    Graham, Rondell P.
    Garcia, Joaquin J.
    Greipp, Patricia T.
    Fritcher, Emily G. Barr
    Kipp, Benjamin R.
    Torbenson, Michael S.
    HISTOPATHOLOGY, 2016, 68 (05) : 686 - 692
  • [38] FGFR1, 2 and 3 protein overexpression and molecular aberrations of FGFR3 in early stage non-small cell lung cancer
    Theelen, Willemijn S. M. E.
    Mittempergher, Lorenza
    Willems, Stefan M.
    Bosma, Astrid J.
    Peters, Dennis D. G. C.
    van der Noort, Vincent
    Japenga, Eva J.
    Peeters, Ton
    Koole, Koos
    Sustic, Tonci
    Blaauwgeers, J. L.
    van Noesel, Carel J.
    Bernards, Rene
    van den Heuvel, Michel M.
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2016, 2 (04): : 223 - 233
  • [39] ULTRARAPID FGFR3 IMMUNOSTAINING FOR DIAGNOSIS OF GLIOMAS HARBORING FGFR3 GENE FUSIONS
    Mantyla, S.
    Haapasalo, J.
    Ilvesaro, J.
    Nordfors, K.
    Isola, J.
    Haapasalo, H.
    Nykter, M.
    Granberg, K.
    NEURO-ONCOLOGY, 2018, 20 : 298 - 298
  • [40] Validation of FGFR3 immunohistochemistry as a predictor of FGFR3 genetic alterations in urothelial carcinoma
    Lopez Del Campo, R.
    Mercader, C.
    Calderon, R.
    Albaiges, J.
    Ferrer-Mileo, L.
    Ribera-Cortada, I.
    Trias, I.
    Vilaseca, A.
    Rodriguez-Carunchio, L.
    VIRCHOWS ARCHIV, 2024, 485 : S172 - S172